Real-world data show DoxyPEP implementation among PrEP users significantly reduces the incidence of chlamydia and syphilis.
The Star Worldwide (English) on MSN
Kenya to begin once-in-six-months HIV prevention injection
Kenya will this year begin rolling out a new long-acting injectable HIV prevention drug, Lenacapavir, positioning the country ...
A brand new drug might be more effective at preventing HIV than current methods. Many people take daily oral antiretroviral medication—known as PrEP (pre-exposure prophylaxis)—to protect themselves ...
In their research article published in Eurosurveillance, von Schreeb et al. challenge existing assumptions regarding the relationship between the use of HIV pre-exposure prophylaxis (PrEP) and the ...
The CDC estimates 2.2 million Americans could benefit from HIV prevention drugs, but just over a quarter of that group have ...
Brazil's Health Regulatory Agency (Anvisa) approved on Monday the use of the drug Sunlenca (lenacapavir) for HIV-1 prevention ...
The Kenya Times on MSN
Kenya to introduce long-acting HIV prevention drug in landmark move
Kenya has taken a major step towards expanding HIV prevention options after the Ministry of Health formally recommended the ...
AllAfrica on MSN
Six-month HIV prevention injection set for rollout by year-end
The government plans to introduce lenacapavir, a long-acting injectable drug for HIV prevention, in the last quarter of the year, according to Rwanda Biomedical Centre (RBC).The injection, given once ...
Allowing people to access HIV prevention treatment through community pharmacies could be a "game-changer" in the fight against the virus, experts have said. While most pre-exposure prophylaxis (PrEP) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback